ARISE, one of the winning projects of TTAccelerator within the PerfeTTO network, was presented at the PerfeTTO Match Up in Milan on September 22 and 23.

On the occasion of the 2025 European Researchers' Night, the OncoAI platform was presented for the first time to all attendees.

Dr. Raffaella Massafra has been appointed Scientific Director of the Oncological Institute of Bari.

In 2024, our Institute was among the protagonists of the Report episode dedicated to artificial intelligence and its applications in health and scientific research.

In 2024, our Institute was featured in an episode of TgR Leonardo for obtaining the patent for the ARISE project.

A feature dedicated to the early developments of the ARISE project and its clinical applications.

The current research results for 2024 from our institute.

With artificial intelligence, we beat breast cancer to the punch - the patent inventor speaks.

A RAI News feature on the use of artificial intelligence in oncological diagnosis at our Institute.

ANSA reports on how AI-powered analysis is reducing time and costs in breast cancer diagnosis in Bari.

Listen to the podcast dedicated to our research on artificial intelligence in oncology.

Our Institute received the AIIC Award for excellence in oncological research.

Our Institute received the IFODS Award.

Our Institute received the ACC Award from Alleanza Contro il Cancro.

Our Institute participated in Health Forum 2024, among the protagonists of the debate on innovation in oncology.

Our team's participation in the ESMO AI 2025 conference on artificial intelligence in oncology.

Maria Colomba Comes presented on digital pathology: AI applied to digitized biopsies predicts response to neoadjuvant therapy in breast cancer patients.

Researchers Maria Colomba Comes and Samantha Bove participated in the PhD Days on "Big Data and Panel Data Analysis", showing how healthcare big data can be analyzed with AI models.

Samantha Bove participated in the PerfeTTO Match-Up, the first international business matching event bringing together 54 Technology Transfer Offices in Milan. ARISE is one of 17 winners of the TT Accelerator program.

Tetiana Skrypets and Maria Colomba Comes selected for the European course "How to Develop and Write a Successful Grant Application" organized by the Organisation of European Cancer Institutes (OECI) in Warsaw.

At the Italian Melanoma InterGroup (IMI) congress in Catania, Raffaella Massafra presented on AI as a tool to improve diagnosis and prognosis. Three posters were presented by our team.

The Biostatistics and Bioinformatics Laboratory is among the very few Italian centers at ESMO AI 2025 in Berlin, with five scientific posters on AI and digital oncology applications.

Our OncoAI project won the national award for Best AI Project in Healthcare – Diagnostics at the Forum Risk Management in Arezzo, beating over 60 projects from across Italy.

Two days on artificial intelligence and its concrete applications in oncology: from prevention to diagnostics, to personalized therapies and clinical data management.

Seven researchers from our Institute participated in the Bari selections of FameLab International, bringing the value of our research with commitment and passion.

The Biostatistics and Bioinformatics Laboratory was a protagonist at the fourth edition of the international "AI for Oncology" congress hosted by Politecnico di Milano, coordinated by Scientific Director Raffaella Massafra.

Our Institute contributed to the 2nd edition of the Atelier della Prevenzione, promoted by the DARE Foundation, on digital prevention in oncology.

Researchers Debora Cafaro and Andrea Lupo participated in the 22nd European Congress on Digital Pathology (ECDP2026) in Graz, presenting our digital pathology and AI projects.

The "System and method for classifying the metastatic status of a sentinel lymph node" receives a European patent: AI analyzes ultrasound images to predict lymph node status without biopsy.

The Istituto Tumori di Bari patents AI for sentinel lymph node assessment, reducing invasive surgery. The European patent was granted to the biostatistics and bioinformatics laboratory team.